Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

Share Price is delayed by 15 minutes
Get Live Data
41.12    -1.44 (-3.38%)
Bid:
41.06
Ask:
43.48
Spread: 2.42 (5.894%)
Market Cap: £416.42m
AML Live PriceLast checked at - London Stock Exchange

Intraday Aston Martin Lagonda Share Chart

Holding(s) in Company - Replacement

14 Jan 2016 16:46

The issuer advises that the following replaces the Amlin plc Holding(s) in Company announcement released at 04:03 PM GMT on January 13, 2016.

Please replace the original form with the following corrected version due to multiple revisions.

All other details remain unchanged.

The full corrected version is shown below.

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Amlin plc

2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments X
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to thenotification obligation: iii JPMorgan Chase & Co.
4. Full name of shareholder(s)(if different from 3.):iv J.P. Morgan Securities Plc
5. Date of the transaction and date onwhich the threshold is crossed orreached: v 11 January 2016
6. Date on which issuer notified: 13 January 2016
7. Threshold(s) that is/are crossed orreached: vi, vii 3% upwards in Financial Instruments

5%,4% downwards in voting rights attached to Shares

8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction Resulting situation after the triggering transaction
NumberofShares NumberofVotingRights Numberof shares Number of votingrights % of voting rights x
Direct Direct xi Indirect xii Direct Indirect
GB00B2988H17 29,104,908 29,104,908 20,128,082 3.99%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financialinstrument Expirationdate xiii Exercise/ Conversion Period xiv Number of votingrights that may beacquired if theinstrument isexercised/ converted. % of votingrights
Right of Recall 2,370,000 0.47%
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financialinstrument Exercise price Expiration date xvii Exercise/Conversion period xviii Number of voting rights instrument refers to % of voting rights xix, xx
Equity Swap 14,622,894 Nominal Delta
2.90%
Total (A+B+C)
Number of voting rights Percentage of voting rights
37,120,976 7.36%
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi
Total disclosable holding for JPMorgan Chase & Co. : 37,120,976 (7.36%)

Direct: J.P. Morgan Securities Plc: 20,128,082 (3.99%) Shares; 14,622,894 (2.90%) Equity Swap; 2,370,000 (0.47%) Right of Recall.

Chain of control:

JPMorgan Chase & Co.

JPMorgan Chase Bank, National Association (100%)

J.P. Morgan International Inc. (100%)

Bank One International Holdings Corporation (100%)

J.P. Morgan International Finance Limited (100%)

J.P. Morgan Capital Holdings Limited (100%)

J.P. Morgan Chase (UK) Holdings Limited (99.99%)

J.P. Morgan Chase International Holdings (100%)

J.P. Morgan Securities plc (99.41%)

Proxy Voting:
10. Name of the proxy holder: N/A
11. Number of voting rights proxy holder will ceaseto hold: N/A
12. Date on which proxy holder will cease to holdvoting rights: N/A
13. Additional information:

Amlin plc

14. Contact name: Mark Stevens, Group Company Secretary
15. Contact telephone number: 020 7746 1000

View source version on businesswire.com: http://www.businesswire.com/news/home/20160114005988/en/

Copyright Business Wire 2016

Date   Source Headline
4th Jun 20267:00 amRNSIssue of equity to satisfy share awards
15th May 20267:00 amRNSIssue of equity to satisfy employee share awards
6th May 202612:51 pmRNSVoting results of AGM 2026
29th Apr 20267:00 amRNSQ1 results for three months ended 31 March 2026
25th Mar 20269:53 amRNSAnnual Financial Report
9th Mar 202612:12 pmRNSResult of Meeting
25th Feb 20267:00 amRNSPreliminary Results FY2025
20th Feb 20267:00 amRNSNotice of GM and FY 2025 Trading Update
29th Oct 20257:00 amRNSQ3 results for the quarter ended 30 September 2025
6th Oct 20257:00 amRNSQ3 2025 Trading Update and revised outlook
10th Sep 202511:33 amRNSDirector/PDMR Shareholding
5th Sep 20257:00 amRNSIssue of equity to satisfy employee share awards
30th Jul 20257:00 amRNSInterim results
28th Jul 20254:33 pmRNSDirectorate Change
27th May 202510:13 amRNSDirector/PDMR Shareholding
27th May 202510:12 amRNSDirector/PDMR Shareholding
15th May 202510:38 amRNSHolding(s) in Company
13th May 20255:26 pmRNSHolding(s) in Company
13th May 202510:33 amRNSDirector/PDMR Shareholding
13th May 202510:31 amRNSDirector/PDMR Shareholding
13th May 202510:26 amRNSDirector/PDMR Shareholding
12th May 20255:53 pmRNSHolding(s) in Company
12th May 20251:13 pmRNSHolding(s) in Company
12th May 202512:52 pmRNSHolding(s) in Company
7th May 20252:45 pmRNSDirector/PDMR Shareholding
7th May 20251:15 pmRNSResult of General Meeting and issue of equity
7th May 20251:07 pmRNSVoting Result of AGM
30th Apr 20257:00 amRNS1st Quarter Results
17th Apr 20258:57 amRNSNotice of General Meeting
16th Apr 20253:20 pmRNSDirector Declaration
31st Mar 20255:11 pmRNSStatement regarding media comments
31st Mar 20257:00 amRNSProposed investment by Yew Tree Consortium
26th Mar 20259:24 amRNSAnnual Financial Report
26th Feb 20257:00 amRNSPreliminary results year ended 31 December 2024
25th Feb 202510:00 amRNSIndependent Non-executive Director appointment
7th Feb 20255:29 pmRNSHolding(s) in Company
13th Dec 20249:00 amRNSDirectorate Change
4th Dec 20244:00 pmRNSHolding(s) in Company
29th Nov 20244:15 pmRNSHolding(s) in Company
29th Nov 20241:01 pmRNSHolding(s) in Company
29th Nov 202412:46 pmRNSDirector/PDMR Shareholding Replacement
29th Nov 202412:18 pmRNSDirector/PDMR Shareholding
29th Nov 202412:17 pmRNSDirector/PDMR Shareholding
29th Nov 202412:11 pmRNSDirector/PDMR Shareholding
27th Nov 20247:00 amRNSResult of Equity Issue
26th Nov 20245:06 pmRNSIssue of Equity
26th Nov 20244:58 pmRNSIssue of Equity
6th Nov 202410:37 amRNSDirector/PDMR Shareholding
30th Oct 20247:00 amRNS3rd Quarter Results
30th Sep 20247:00 amRNSTrading Update and adjustment to FY 2024 guidance

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.